|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Dengue | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Dengue Hemorrhagic Fever | |||||
| 3 | More general conditions related to this trial | ||||
| Arbovirus Infections | |||||
| Flaviviridae Infections | |||||
| Flavivirus Infections | |||||
| Hemorrhagic Fevers, Viral | |||||
| RNA Virus Infections | |||||
| Virus Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| rDEN4delta30-4995 | |||||
| Placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||
| Center for Immunization Research | |||||